- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Subjects With Clinical Indication for PET/CT in United States
Total 28 results
-
GE HealthcareCompletedAny Condition With a Clinical Indication for PET/CT ExamUnited States
-
GE HealthcareTerminatedIndication for a PET CT ExamUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedClinical CT Abdomen/Pelvic With Oral Contrast and SedationUnited States
-
Toshiba America Medical Systems, Inc.UnknownConfirm PCA-9000A PET/CT System is Effective for Its Intended UseUnited States
-
GE HealthcareICON plcCompletedClinical Indication for Brain MRIUnited States
-
GE HealthcareCompletedClinical Indication for a Head MRIUnited States
-
Ohio State UniversityNational Institute of Mental Health (NIMH)CompletedPatients Already Taking Risperidone for Clinical IndicationsUnited States
-
Brigham and Women's HospitalRecruitingIndication for Care or Intervention Related to Labor or Delivery With Baby DeliveredUnited States
-
AO Clinical Investigation and Publishing DocumentationTerminatedClinical Indication for First Metatarsal Joint ArthrodesisUnited States, Colombia, United Kingdom
-
Restor3DTerminatedClinical Condition Included in the Approved Indications For Use for the Conformis Hip SystemUnited States
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal or With Ocular PathologyUnited States
-
Greater Baltimore Medical CenterWithdrawnCancer | Patients With Clinical and Environmental Risk Factors for Cancer | Patients With a Suspected or Confirmed Diagnosis of CancerUnited States
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH); University of California, San FranciscoRecruitingMedication Refractory Epilepsy Patients With Electrodes Already Implanted Based on Clinical Criteria for Standard MonitoringUnited States
-
AmgenCompletedAny Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical TrialCanada, Spain, United States, Germany, Austria, France, Greece, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, South Africa, Switzerland, United Kingdom
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); Takeda Pharmaceuticals North America, Inc.CompletedObesity | Overweight With Indications for Weight LossUnited States
-
DeNova ResearchCompletedSubjects Requesting and Requiring Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid FillersUnited States
-
Albany Medical CollegeCompletedNon-critical Emergency Room Patients Receiving Lortab Medication or Prescription During Their Emergency Room VisitUnited States
-
AstraZenecaEli Lilly and Company; i3 Drug SafetyCompletedType 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)United States
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States
-
University of NebraskaBracco Diagnostics, Inc; Philips Medical SystemsCompletedHepatitis | Fibrosis of Liver | Underlying Liver Disease | Cirrhosis With Suspicion of Liver Cancer | Lesion on a Prior Ultrasound, CT or Outside MRIUnited States
-
Axcella Health, IncCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease | Sickle Cell DisordersUnited States
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
Foresee Pharmaceuticals Co., Ltd.TerminatedSevere to Critical COVID 19 With Associated ARDSUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingAdvanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IVSpain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
-
APR Applied Pharma Research s.a.Lavin Consulting, LLCCompletedAcute Lung Injury | Corona Virus Infection | Acute Respiratory Distress Syndrome (ARDS) | Critical COVID-19 With Respiratory FailureUnited States
-
Anova Enterprises, IncRecruitingNeoplasms | Infectious Disease | External Causes of Morbidity and Mortality | Pregnancy, Childbirth and the Puerperium | Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) | Endocrine, Nutritional and Metabolic Diseases (E00-E89) | Mental... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia